Michael Milligan

Michael Milligan is Neumora’s Chief Financial Officer. He joined Neumora as Senior Vice President of Finance and Principal Accounting Officer in December 2021, where he played a crucial role in guiding Neumora through its financial milestones, including the Company’s successful IPO in 2023. Previously, he served as Vice President of Finance and Corporate Controller at Y-Mabs Therapeutics, Inc. Prior to this, he served as Vice President of Finance and Corporate Controller at Acorda Therapeutics, Inc., Executive Vice President and Chief Financial Officer at New Haven Pharmaceuticals, Inc., and Vice President and Chief Accounting Officer at Shionogi, Inc. He began his career in public accounting at KPMG LLP and Ernst & Young LLP. Mr. Milligan holds a Bachelor of Business Administration with a concentration in Accounting from the University of Miami and a Master of Business Administration from Georgia State University. Mr. Milligan is a Certified Public Accountant.